Manager × security

CITIGROUP INC XBI holdings history

SS SPDR S&P BIOTECH ETF · CUSIP 78464A870 · CIK 831001

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, CITIGROUP INC reported 11.61M XBI (shares), valued at $1.84B, or 0.85% of its reported non-derivative portfolio. Filed 2026-08-03.

Verify history & sources
Portfolio weight and quantity history
Reported portfolio weight
0.85%
Shares
11.61M
11,612,884
Reported value
$1.84B
USD

Shares increased 8.90%; reported value increased 34.93%, and weight changed -0.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20260.85%11,612,884SEC filingFiled Aug 3, 2026
Q1 20260.87%10,663,404SEC filingFiled May 11, 2026
Q4 20251.04%12,527,210SEC filingFiled Feb 13, 2026
Q3 20250.75%10,890,891SEC filingFiled Nov 10, 2025
Q2 20250.73%12,753,740SEC filingFiled Aug 11, 2025
Q1 20250.65%10,477,966SEC filingFiled May 12, 2025
Q4 20240.97%11,151,595SEC filingFiled Feb 12, 2025
Q3 20240.71%7,749,814SEC filingFiled Nov 12, 2024
Q2 20240.65%7,257,438SEC filingFiled Aug 12, 2024
Q1 20240.91%8,822,352SEC filingFiled May 10, 2024
Q4 20230.49%4,108,086SEC filingFiled Feb 9, 2024
Q3 20230.59%5,617,369SEC filingFiled Dec 6, 2023Amended

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20230.59%5,617,369$410.18MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing
Filed Dec 6, 2023
Q4 20230.49%4,108,086$366.81MShares decreased 26.87%; reported value decreased 10.57%, and weight changed -0.10 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Feb 9, 2024
Q1 20240.91%8,822,352$837.15MShares increased 114.76%; reported value increased 128.22%, and weight changed +0.42 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed May 10, 2024
Q2 20240.65%7,257,438$672.84MShares decreased 17.74%; reported value decreased 19.63%, and weight changed -0.26 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Aug 12, 2024
Q3 20240.71%7,749,814$765.68MShares increased 6.78%; reported value increased 13.80%, and weight changed +0.06 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Nov 12, 2024
Q4 20240.97%11,151,595$1.00BShares increased 43.90%; reported value increased 31.17%, and weight changed +0.26 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Feb 12, 2025
Q1 20250.65%10,477,966$849.76MShares decreased 6.04%; reported value decreased 15.39%, and weight changed -0.32 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed May 12, 2025
Q2 20250.73%12,753,740$1.06BShares increased 21.72%; reported value increased 24.47%, and weight changed +0.08 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Aug 11, 2025
Q3 20250.75%10,890,891$1.09BShares decreased 14.61%; reported value increased 3.18%, and weight changed +0.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Nov 10, 2025
Q4 20251.04%12,527,210$1.53BShares increased 15.02%; reported value increased 39.97%, and weight changed +0.29 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Feb 13, 2026
Q1 20260.87%10,663,404$1.36BShares decreased 14.88%; reported value decreased 10.83%, and weight changed -0.17 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed May 11, 2026
Q2 20260.85%11,612,884$1.84BShares increased 8.90%; reported value increased 34.93%, and weight changed -0.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Aug 3, 2026
CITIGROUP INC · SS SPDR S&P BIOTECH ETF

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"831001","quarter":"2026Q2","cusip":"78464A870"}

get_institutional_manager_history
{"cik":"831001","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.